Fertility Test Market size was valued at USD 588.81 million in 2024 and is poised to exceed USD 1.67 billion by the end of 2037, expanding at over 8.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of fertility test is evaluated at USD 628.38 million.
The market growth is primarily being attributed to the growing prevalence of polycystic ovarian syndrome among female population. Between 4% and 20% of people worldwide are believed to have PCOS. According to estimates from the World Health Organization (WHO), PCOS affects about 116 million women worldwide (3.4%).
Besides this, the rise in the number of people suffering with infertility is expected to boost the growth of the fertility test market. There are many factors that contribute to infertility, including low sperm count and limited sperm motility in men and failure to ovulate, damaged cervixes and fallopian tubes in women. The World Health Organization (WHO) statistics show that 186 million people worldwide, including 45 million couples, are infertile. Furthermore, the integration of technology in fertility test is also anticipated to augment the market growth. For instance, the development of artificial intelligence in IVF could be advantageous to the entire process. According to the National Library of Medicine, AI can recognize human sperm with an accuracy of 89.9% and properly forecast whether a live delivery will occur.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
8.3% |
Base Year Market Size (2024) |
USD 588.81 million |
Forecast Year Market Size (2037) |
USD 1.67 billion |
Regional Scope |
|
End-user (Home Care, Fertility Clinics, Hospitals)
The global fertility test market is segmented and analyzed for demand and supply by end user into home care, fertility clinics, and hospitals. Out of all, the home care segment is anticipated to hold the largest market size by the end of 2037. the segment growth is anticipated on the account of higher number of people using fertility test at home and there have been significant rise in male home-fertility testing as the rate of infertility is constantly increasing. Around 40%-50% of fertility problems in couple is attributed to male fertility.
Our in-depth analysis of the global market includes the following segments:
By Product |
|
By Mode of Purchase |
|
By End User |
|
North America Market Forecast
The North America fertility test market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market in the North America, the market growth is expected to grow on the back of, rise in the cases of infertility. In the United States, 1 in 5 heterosexual women between the ages of 15 and 49 who have never given birth are unsuccessful in getting pregnant after a year of trying (infertility). Additionally, 26% of the women in this group report having trouble getting pregnant or bringing a pregnancy to term. Furthermore, the rise in the average age of women conceiving for the first time is to propel the rate infertility. Birthrates for women in their 20s have decreased, while those for women in their late 30s and early 40s have increased in the U.S. The median age of U.S. women giving birth has increased from 27 to 30, the highest age ever.
Kindbody launched the Kind at Home fertility test for both men and women. It can be easily used at home; it also provides detailed information about the fertility status along with customizes recommendation by doctors.
Fertility Focus launched the OvyFirst, it is sensor device which estimates the body temperature and predict best time for the women to conceive
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?